Posted on June 23, 2011 by Sitemaster
So-called “hot flashes” are a common and annoying side effect of androgen deprivation therapy for many men with high-risk and advanced forms of prostate cancer. A new study has suggested that an extract of common, garden sage (Salvia officinalis) may be an effective dietary supplement that can significantly lower frequency and intensity of hot flashes. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation, extract, hot flashes, sage, Salvia officinalis | 1 Comment »
Posted on June 6, 2011 by Sitemaster
Perhaps the most interesting new data from the annual meeting of the American Society of Clinical Oncology yesterday (Sunday) was a negative result from a four-arm, randomized clinical trial. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, Effexor, hot flashes, soy, venlaxafine | 3 Comments »
Posted on January 19, 2011 by Sitemaster
There are new data showing that the antidepressant escitalopram (Lexapro/Forest) — a selective serotonin re-uptake inhibitor or SSRI — can significantly reduce hot flashes among women undergoing menopause. If that is the case, one wonders whether drugs of this class might have a similar impact on hot flashes in men on androgen deprivation therapy (ADT). … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: hot flashes, Management, Prevention, SSRIs | 2 Comments »
Posted on August 21, 2010 by Sitemaster
Many patients have sought out acupuncture as a method to gain relief from hot flashes associated with androgen deprivation therapy (ADT). However, data from prospective clinical trials is at best limited. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: acupuncture, ADT, androgen deprivation, hot flashes, trial | 3 Comments »
Posted on December 22, 2009 by Sitemaster
There are three fairly significant news reports today dealing with the following issues:
- The relationship between a family history of prostate cancer and age at diagnosis
- The impact of RALP on selection of surgery as a first-line treatment option
- The management of ADT-related hot flashes … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: family history, hot flashes, RALP, robot-assisted laparoscopic prostatectomy, Treatment | Leave a comment »
Posted on March 21, 2009 by Sitemaster
This weekend’s news reports include items on:
- Androgen pathway genes and prostate cancer risk
- Pre-treatment PSA doubling time and prediction of Gleason score
- The diagnosis of prostate cancer in men with a diagnosis of HG-PIN
- Neoadjuvant hormone therapy in men undergoing brachytherapy
- Acupuncture as a means to manage hot flashes … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: acupuncture, androgen pathway genes, brachytherapy, Diagnosis, HG-PIN, hot flashes, neoadjuvant hormone therapy, polymorphism, pre-treatment PSA doubling time | 2 Comments »
Posted on January 21, 2009 by Sitemaster
Today’s news includes information on:
- The use of markers for prognosis following first-line treatment for localized prostate cancer
- Results of a Phase II trial of neoadjuvant docetaxel + gefitinib prior to radical prostatectomy
- Results of a Phase III trial of gabapentin in management of ADT-related “hot flashes”
- MRI-directed HIFU in the treatment of localized prostate cancer … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: docetaxel, doubling time, gabapentin, gefitinib, HIFU, hot flashes, PSA velocity | Leave a comment »
Posted on October 31, 2008 by Sitemaster
We have separately commented on a Swedish pilot study showing that men treated with captopril following radical prostatectomy had a significant reduction in risk of biochemical recurrence. Other reports today deal with:
- The potential of contrast enhanced eMRI in diagnosis and monitoring
- Whether we can better identify high-risk patients with localized disease for curative surgery
- Early-stage patients and risk for prostate cancer-specific mortality
- Hot flashes and depression … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", contrast-enhanced eMRI, depression, hot flashes, mortality, surgery | Leave a comment »